CONTRACT RESEARCH OUTSOURCING

Global Market Trajectory & Analytics

MCP-1534

EXECUTIVE ENGAGEMENTS

OUTREACH

1653
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

298
Interactions with Platform & by Email

PARTICIPANTS

66
Unique # Participated

VALIDATIONS

31
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2021

TABLES

132

PAGES

453

EDITION

16

PRICE

USD $5800


The global market for Contract Research Outsourcing is expected to slump by -1.9% in the year 2020 and thereafter recover to reach US$72.1 billion by the year 2027, trailing a post COVID-19 CAGR of 7% over the analysis period 2020 through 2027. The COVID-19 crisis has thrown various challenges for the pharmaceutical & biopharmaceutical contract research outsourcing industry, while opening new avenues for growth across different domains. Contract research organizations serving pharmaceutical and vaccine companies were coerced to discontinue several studies owing to restrictions regarding movement of goods along with face-to-face interactions. These mandates affected central laboratories, clinical trial sites and timelines for completion of sponsored studies. Stringent guidelines enforced by countries prevented face-to-face meetings with clients, which delayed resolution of technical issues. The situation prompted various organizations to resort to video conferencing along with advanced technologies for addressing these issues. On the positive side, the COVID-19 pandemic drove the adoption of e-Clinical systems and offered new opportunities for pandemic-related research. The outbreak and associated changes in strategies required companies to bring their projects online and comply with high visibility and tight timelines. Various organizations implemented e-Clinical systems to avoid face-to-face interactions, enabling providers of these solutions to reap rich dividends. While the pandemic affected existing projects, it enabled the pharmaceutical & biopharmaceutical outsourcing industry to witness notable surge in R&D demand.


The trend prompted companies to shift their focus and fine-tune existing operations to ensure efficiency for COVID-19-related projects. In addition, the work-from-home trend and repurposing of projects enabled various players to pay more attention to strategic activities. The pandemic has brought various changes in the CRO industry by delaying clinical trials, requiring repurposing of development pipeline and prompting companies to explore new options to connect with patients. Factors like patient disinclination to travel and local restrictions made companies to delay or stop non-essential study visits. Organizations were affected by customer-related trial delays, access and limitations to specific trial sites, and disruptions in the supply chain. The shift towards COVID-19 vaccine and treatments increased the workload for CROs. Known for their high capacity and flexibility, majority of CROs effectively accommodated the volume within a short span. Contract research organizations made concerted efforts towards accommodation of new projects without compromising over existing projects for other medical conditions or indications. The pandemic is anticipated to benefit the biopharmaceutical drug development industry and strengthen drug development activity, requiring players to efficiently use digital solutions, data insights and patient engagements. Easing of restrictions and reopening of businesses are likely to bring non-COVID-19 trials on track and drive organizations to pay more attention to decentralized clinical trial solutions including digital platforms along with mobile phlebotomists and nurses. In addition, these clinical trials are expected to reduce the requirement for patients and other participants to travel, which remains a major challenge during the current scenario.


Changes in business operations for pharmaceutical companies are prompting CROs and other participants to adjust their practices. The impact of COVID-19 on face-to-face interactions with clients is driving various companies to implement new platforms for virtual connectivity. The technology is enabling organizations with global operations to efficiently serve their customers. In addition to limiting employee travel and considering remote working, organizations are adopting wearable cameras to assist clients in virtual audits and plant visits. These virtual meetings are providing an effective alternative to traditional personal contacts, on-site visits and face-to-face interactions. In addition, organizations are working closely with procurement teams for sourcing necessary supplies to ensure operational continuity and serve clients in a better way. The COVID-19 healthcare emergency has created a pressing need for a collaborative approach among health authorities, pharmaceutical players, regulators and CROs for developing and producing safe and effective treatments. The holistic approach combining resources and the required expertise is expected to pave way for efficient distribution of the impending vaccine globally. CROs are partnering with pharmaceutical companies for targeting data integrity and patient safety, as well as with other stakeholders including regulators and sites for patient safety-related considerations. Players are also implementing sophisticated solutions for research sites and clinical studies to reduce the burden on healthcare providers, patients and investigational sites. CROs are anticipated to play a critical role during the pandemic by taking responsibility for consistent on-site support.

SELECT PLAYERS

Albany Molecular Research, Inc.; Charles River Laboratories International, Inc.; Covance Clinical Biotech; ICON plc; IQVIA Inc; Jubilant Biosys Ltd.; Laboratory Corporation of America® Holdings; Olon Ricerca Bioscience; PAREXEL International Corp.; Pharmaceutical Product Development, LLC.; Pharmaron; PRA Health Sciences, Inc.; Sygnature Discovery Limited; Syneos Health; SynteractHCR; WuXi AppTec

SEGMENTS

» Service Type (Clinical, Discovery, Pre-Clinical, Laboratory Services) » End-Use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » India » Rest of Asia-Pacific » Latin America » Rest of World

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

  
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry
Players Focus on Collaborative Approach
Optimism Reigns in Latter Part of 2020
COVID-19 and Implications for Drug Development Regulations & Processes
Opportunities in COVID-19 Programs
Parallel Gains for Development & Manufacturing
Contract Research Outsourcing: An Introduction
Key Service Markets
Market Dynamics
Key Therapeutic Areas of Clinical Trial Research
EXHIBIT: Global Clinical Trial Services Market by Therapeutic Area: 2019
Cost Savings Hold Relevance
Product Innovations & Enhanced Speed
Access to Expertise & Sophisticated Technology
Outlook
Regional Market Analysis
Future Model of CRO
COMPETITIVE SCENARIO
CRO: A Highly Fragmented Market
EXHIBIT: Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player
Partnership Models Pay Returns
Strategies and Tactical Programs
Large CROs Seek the Inorganic Growth Route
Key Opportunities for CROs
Technological Superiority: An Advantage
Consolidation to Gain Pace
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Uptrend in Advanced Medicine Concepts Favors Growth
Drug Developers Bet on CROs to Sail through Challenging Aspects
Pharmaceutical & Biopharmaceutical Firms Target Outsourcing
Gene Therapy Offers Exciting Opportunities for CROs
COVID-19 Creates a Pause in Gene Therapy Market Growth
Gene Therapy Set to Witness Rapid Growth Post COVID-19
EXHIBIT: Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026
Increasing Significance of Biologic Drugs Supports Market Demand
EXHIBIT: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
COVID-19 Drives Strong Gains for Biologics Activity
Opportunities Rife in Early Stage Drug Development
Notable Trends in Pharma/Biopharma R&D Impacting CROs
Advances in Digital/Technology and its Impact on Clinical Development
Significant Strides Taken in the Sphere of Current Clinical Research
Data Quality Oversight (DQO) Undergoes Change
Pharmacovigilance Set to Grow
Artificial Intelligence and Machine Learning Gain Interest
Orphan Drugs to the Fore
CROs Adapt New Technologies to See More Business in Future
Streamlining Development of Novel Trial Designs
Industry Witnesses Increased Spend on R&D Outsourcing
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
EXHIBIT: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019
Focus on Enhancing Site Selection and Patient Enrollment
CROs Enter into Alliances to Improve Efficiencies
Adoption of Digital Technologies Gains Pace
Toxicology Services Gain Notable Attention
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
EXHIBIT: Global Biopharma % R&D Outsourcing (2014-2022)
EXHIBIT: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
eClinical Solutions Gain Traction
Other Noteworthy Market Trends
Challenges Faced by Contract Research Organizations
Surging Global Population Offers Increased Growth Opportunities
EXHIBIT: World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050
Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045)
Increasing Healthcare Expenditure and Demand for Generics to Drive Growth
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
Market Overview
COVID-19 Pandemic: Mixed Bag of Opportunities for CROs
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
Trial Services Witness Strong Demand
High Demand for Data Management Services
Risk-based Monitoring Catches Pace
Market Analytics
USA Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
USA 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
USA 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Canada 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Canada 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Japan 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Japan 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
CHINA
Market Overview
China Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
China 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
China Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
China 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
EUROPE
Market Overview
Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments
Providers Expand Services in Downstream Drug Development
Market Analytics
Europe Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Europe 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
France 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
France Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
France 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Germany 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Germany 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Italy 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Italy 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
UK 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
UK 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Spain 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Spain 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Russia 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Russia 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Market Overview
Asia-Pacific to Push Up Volume Share in CRO Market
R&D Outsourcing in Life Sciences on Rise
Market Analytics
Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027
Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
INDIA
Indian CROs Seek Opportunities
India Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
India 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
India Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
India 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Market Overview
Australia: Popular Destination for Early Phase Clinical Trials
Market Analytics
Rest of Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of Asia-Pacific 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Latin America 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Latin America 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of World 15-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027
Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019
Rest of World 15-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2012, 2020 & 2027
Total Companies Profiled : 152

Click here to request a full table of contents and more details on this project.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL